Literature DB >> 28288515

Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder.

Bianca Christensen1, Zijian Qin2, Desiree A Byrd3, Fang Yu4, Susan Morgello3, Benjamin B Gelman5,6, David J Moore7, Igor Grant7, Elyse J Singer8, Howard S Fox9, Lorena Baccaglini2.   

Abstract

With the transition of HIV infection from an acute to a chronic disease after the introduction of antiretroviral medications, there has been an increased focus on long-term neurocognitive and other functional outcomes of HIV patients. Thus, we assessed factors, particularly history of a substance use disorder, associated with time to loss of measures of physical or mental independence among HIV-positive individuals. Data were obtained from the National NeuroAIDS Tissue Consortium. Kaplan-Meier and Cox proportional hazards regression analyses were used to estimate the time since HIV diagnosis to loss of independence, and to identify associated risk factors. HIV-positive participants who self-identified as physically (n = 698) or mentally (n = 616) independent on selected activities of daily living at baseline were eligible for analyses. A history of substance use disorder was associated with a higher hazard of loss of both physical and mental independence [adjusted hazard ratio (HR) = 1.71, 95% confidence interval (95% CI): 1.07-2.78; adjusted HR = 1.67, 95% CI: 1.11-2.52, respectively]. After adjusting for substance use disorder and other covariates, older age at diagnosis and female gender were associated with higher hazards of loss of both physical and mental independence, non-white participants had higher hazards of loss of physical independence, whereas participants with an abnormal neurocognitive diagnosis and fewer years of education had higher hazards of loss of mental independence. In summary, history of substance use disorder was associated with loss of measures of both physical and mental independence. The nature of this link and the means to prevent such loss of independence need further investigation.

Entities:  

Keywords:  HIV; activities of daily living; mental independence; neuroAIDS; physical independence; substance abuse

Mesh:

Substances:

Year:  2017        PMID: 28288515      PMCID: PMC5650716          DOI: 10.1089/AID.2016.0269

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  25 in total

1.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

2.  Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users.

Authors:  Kaitlin B Casaletto; David J Moore; Steven Paul Woods; Anya Umlauf; J C Scott; Robert K Heaton
Journal:  Clin Neuropsychol       Date:  2016-01-12       Impact factor: 3.535

3.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

4.  Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Authors:  Erin E Morgan; Steven Paul Woods; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-02-15       Impact factor: 2.813

5.  An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection.

Authors:  Pariya L Fazeli; Steven Paul Woods; Robert K Heaton; Anya Umlauf; Ben Gouaux; Debra Rosario; Raeanne C Moore; Igor Grant; David J Moore
Journal:  J Neurovirol       Date:  2014-02-20       Impact factor: 2.643

6.  Cognitive disorders in HIV-infected patients: are they HIV-related?

Authors:  Fabrice Bonnet; Hélène Amieva; Fabienne Marquant; Charlotte Bernard; Mathias Bruyand; Frédéric-Antoine Dauchy; Patrick Mercié; Carine Greib; Laura Richert; Didier Neau; Gwenaelle Catheline; Patrick Dehail; Francois Dabis; Philippe Morlat; Jean-François Dartigues; Geneviève Chêne
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

7.  Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Authors:  Rita B Effros; Courtney V Fletcher; Kelly Gebo; Jeffrey B Halter; William R Hazzard; Frances McFarland Horne; Robin E Huebner; Edward N Janoff; Amy C Justice; Daniel Kuritzkes; Susan G Nayfield; Susan F Plaeger; Kenneth E Schmader; John R Ashworth; Christine Campanelli; Charles P Clayton; Beth Rada; Nancy F Woolard; Kevin P High
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

8.  HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.

Authors:  Lucette A Cysique; Robert K Heaton; Jody Kamminga; Tammy Lane; Thomas M Gates; Danielle M Moore; Emma Hubner; Andrew Carr; Bruce J Brew
Journal:  J Neurovirol       Date:  2014-04-03       Impact factor: 2.643

9.  Shallow encoding and forgetting are associated with dependence in instrumental activities of daily living among older adults living with HIV infection.

Authors:  Pariya L Fazeli; Katie L Doyle; J Cobb Scott; Jennifer E Iudicello; Kaitlin B Casaletto; Erica Weber; David J Moore; Erin E Morgan; Igor Grant; Steven Paul Woods
Journal:  Arch Clin Neuropsychol       Date:  2014-04-02       Impact factor: 2.813

10.  Successful cognitive aging in persons living with HIV infection.

Authors:  Lauren Malaspina; Steven Paul Woods; David J Moore; Colin Depp; Scott L Letendre; Dilip Jeste; Igor Grant
Journal:  J Neurovirol       Date:  2010-11-30       Impact factor: 2.643

View more
  1 in total

1.  HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus.

Authors:  Sara R Nass; Arianna R S Lark; Yun K Hahn; Virginia D McLane; Therese M Ihrig; Liangru Contois; T Celeste Napier; Pamela E Knapp; Kurt F Hauser
Journal:  Horm Behav       Date:  2021-06-23       Impact factor: 3.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.